| Name | NF-κΒ activator 2 |
| Description | NF-κΒ Activator 2 is a potent, orally active compound that efficiently activates NF-κB with an EC50 value of 1.58 μM. By enhancing NF-κB expression and activation, it induces SOD 2 synthesis, rendering it useful for amyotrophic lateral sclerosis (ALS) research [1]. |
| In vitro | NF-κB activator 2 (Compound 61) (1 μM, 6 hr) induces SOD 2 mRNA expression in SH-SY5Y neuroblastoma cells [1]. SOD2 is a highly inducible SOD that performs in concurrence with SOD1 to detoxify ROS. Induction of SOD2 can be obtained through the activation of NF-ҡBs. |
| In vivo | NF-κΒ activator 2, when administered intravenously (i.v.) at a dose of 1 mg/kg, demonstrates an appropriate half-life of 0.96 hours in mice [1]. Similarly, at an oral (p.o.) dosage of 5 mg/kg, it shows a comparable half-life of 2.86 hours, an oral bioavailability of 15.6%, and a maximum concentration (C max) of 92 ng/mL [1]. |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 5 mg/mL (16.76 mM), Sonication is recommended.
DMSO : 250 mg/mL (838.17 mM), Sonication is recommended.
|
| Keywords | SOD2 | sclerosis | Nuclear factor-κB | Nuclear factor-kappaB | NF-κΒ activator 2 | NFκΒ activator 2 | NF-κB | NFκB | NF-kb activator 2 | NF-kB | NFkB | NF-kappabeta activator 2 | NF-?B | NF κΒ activator 2 | lateral | Inhibitor | inhibit | amyotrophic | ALS |
| Inhibitors Related | Undecane | Sodium propionate | Ethyl palmitate | Kojic acid | Uridine | Fumaric acid | Methylamine HCl | 1,4-Naphthoquinone | Glucosamine | Ethyl linoleate | N,N-Dimethylacetamide | Magnesium sulfate |
| Related Compound Libraries | NF-κB Signaling Compound Library | Bioactive Compound Library | Hematonosis Compound Library | Anti-Breast Cancer Compound Library | Neuroprotective Compound Library | Anti-Prostate Cancer Compound Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Fluorochemical Library | Anti-Cancer Compound Library | Transcription Factor-Targeted Compound Library |
United States
